ThursdayFeb 18, 2021 2:30 pm

Massachusetts General Hospital to Study How Psychedelics Influence the Brain

Massachusetts General Hospital is partnering with Atai Life Sciences to study the effects of psychedelics on the human brain. Atai Life Sciences is a biotech firm focused on developing medications to manage schizophrenia while also working on creating alternative treatments for various mental health conditions such as anxiety and depression. The two organizations decided to work together after the hospital set up a program, named the Center for Neuroscience of Psychedelics, to study psychedelic therapy. A psychiatric at the hospital, Jerrold Rosenbaum is the head of the program and has specialized in the treatment of psychiatric disorders. Rosenbaum stated that…

Continue Reading

ThursdayFeb 18, 2021 10:01 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Enters Large Cannabis Biomass Agreements to Scale Up Extract Production, Announces DTC Eligibility of Common Shares in the U.S.

Pure Extracts entered into two large biomass purchase agreements, plans to ramp up production of high-potency THC and CBD extracts in 2021 Company expects historically low biomass purchase price will produce $590,000 revenue Company recently announced DTC eligibility of common shares for increased settlement and clearance speeds, wider access to brokerage firms Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company that focuses on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelics sector, recently entered into two substantial cannabis biomass purchase agreements (https://ibn.fm/Vbyxp) in addition to announcing that its common shares are now eligible for…

Continue Reading

WednesdayFeb 17, 2021 2:45 pm

How Past Stigma and Recreational Use Are Slowing Psychedelic Science

According to recent research conducted in America that involved 952 individuals, psychedelic researchers who admitted to using psychedelic substances are often viewed by their abstinent counterparts as having less integrity. The study, which was reported in the “Public Understanding of Science” journal, proposes that stereotypes about both psychedelics and the individuals who use them may affect an individual’s view of researchers. University of Zurich’s Matthias Forstmann, who is the one of the authors of the study, stated that the personal use of these substances by the scientists studying them was a common occurrence, although very few researchers were open about…

Continue Reading

TuesdayFeb 16, 2021 2:14 pm

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Delineates Parameters and Timeline of Study into Psilocybin-Based Active Treatments

Pure Extract Technologies pursues study into psilocybin active treatments Study to extend for 250-day period, targeting a number of milestones The study is set to be carried out at Toronto Institute of Pharmaceutical Technology, will be supervised by Pure Extracts’ scientific advisor, Dr. Alexander MacGregor Oregon recently voted to legalize psilocybin mushrooms for therapeutic use, a potential legislative movement which may soon be replicated in other jurisdictions Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on the cannabis, hemp, and functional mushroom sectors, has provided investors with an update in regards to its ongoing…

Continue Reading

TuesdayFeb 16, 2021 1:30 pm

Cambridge City Councilors Approve Psychedelics Decriminalization Measure

A Massachusetts city may soon be decriminalizing the possession and use of most psychedelics and entheogenic plants. City councilors in Cambridge, Massachusetts, recently approved the policy order, which will also decriminalize all controlled substances. The order was sponsored by Councilor Jivan Sobrinho-Wheeler. Wheeler stated that research had shown that psychedelic fungi and plants, such as psilocybin mushrooms, could be used to treat various substance use and mental health issues. The initiative directed the manager of Cambridge City to cooperate with state and federal partners to decriminalize psychedelics, which are currently classified as controlled substances, in addition to being illegal under…

Continue Reading

FridayFeb 12, 2021 11:00 am

New Jersey Gov Signs Bill Reclassifying Psilocybin

Gov. Phil Murphy of New Jersey recently signed a psilocybin reform measure that reclassified possession of up to one ounce of psilocybin mushrooms under a disorderly persons’ offense. This reclassification means that persons caught with small amounts of psilocybin will be subject to up to six months in jail, a $1000 fine or both. The offense was previously punishable with fines of up to $15 000 and a penalty of three to five years in jail, and was considered a third-degree crime. This change puts psilocybin mushroom possession in the state on par with resisting arrest, shoplifting, harassment or simple…

Continue Reading

ThursdayFeb 11, 2021 2:15 pm

Progressive Doctor Thinks Psychedelics May Be Used to Revive Comatose Patients

Dr. Hyder Khoja is hoping to use psychedelics to treat patients in comas in a bid to stimulate them back into consciousness. Psychedelics have the potential to treat various mental conditions, with more uses still being discovered. There are roughly 59 clinical trials registered around the world that plan on using psilocybin to manage mental health conditions. While a majority of these clinical trials are focusing on mental ailments such as OCD, anxiety and depression, Khoja intends to use these powerful substances to jump-start consciousness in unresponsive patients in comas. Khoja, who received his molecular biology and genetic engineering PhD…

Continue Reading

WednesdayFeb 10, 2021 2:45 pm

War Hero from Ontario Featured in Psychedelic Documentary

A documentary focusing on the area of psychedelic drugs as a potential treatment for mental-health issues. The documentary features several individuals who share their experiences and feelings regarding psychedelics. In the documentary, area war hero Patrick Moulden noted that he is taking a chance on psychedelics in a bid to help manage his mental distress. Russell Peters, a comedian who recently joined a psychedelic firm based in Canada, stated that there were a lot of individuals who suffered from depression, adding that he was one of them. World-renowned addiction specialist Dr. Evan Wood says that psychedelics had enough potential to…

Continue Reading

TuesdayFeb 09, 2021 2:30 pm

Should Montreal Expect Psychedelic Revolution in the Near Future? Activists Think So

Health Canada granted five legal exemptions since August last year to Canadians who had requested access to magic mushroom therapy for both serious mental trauma and end-of-life care. In December, the body had announced that it would be revising its Special Access Program, which would make it easy for individuals (special cases) to access psychedelics. Montreal Psychedelic Society executive director Jessica Cadoch stated in an interview that when the book “How to Change Your Mind” by Michael Pollan came out, momentum on psychedelics increased rapidly. The book, which focuses on the science of psychedelics, was released in 2018, the same…

Continue Reading

MondayFeb 08, 2021 2:00 pm

Connecticut, Florida Legislators File Psychedelic Mushroom Bills

Legislators in Florida and Connecticut have filed new measures to reform state legislations on psychedelic mushrooms. Rep. Michael Grieco filed a bill in Florida last week. The legislation would establish the legal therapeutic use of psilocybin in the state, which is similar to a measure that voters in Oregon passed in November 2020. The main goal of Florida’s initiative is to promote the treatment of various mental health conditions with the help of psilocybin. In addition, Florida’s measure would deprioritize the criminal enforcement of various psychedelic fungi and plants. Florida’s initiative states that psilocybin has demonstrated safety, tolerability and efficacy…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050